#United States #New York #Class Action #Levi Korsinsky #Baxter International

Legal Alert: Baxter International, Inc. Class Action Lawsuit

In a recent announcement, Levi & Korsinsky LLP, a renowned legal firm, has alerted investors of Baxter International, Inc. regarding a class action lawsuit that aims to address significant losses incurred by shareholders. This lawsuit pertains to allegations of securities fraud that occurred between February 23, 2022, and July 30, 2025.

The core of the lawsuit is based on claims that Baxter International's management provided misleading information regarding the safety and efficacy of their product, the Novum Large Volume Pump (LVP). According to the lawsuit, there were systemic defects in the Novum LVP, leading to critical issues such as:

• - Underinfusion and Overinfusion: These malfunctions risked the health of patients by delivering incorrect fluid amounts.
• - Complete Non-Delivery of Fluids: In severe cases, the pump failed to deliver fluids at all, endangering patients' lives.
• - Risk of Serious Injury: The ongoing malfunctions exposed patients to the risk of serious injuries or potentially fatal outcomes.

The complaint further alleges that Baxter was aware of multiple incidents of device malfunctions, including injuries and some fatalities linked to these defects. In response, Baxter's actions to tackle the issue—such as issuing customer alerts—were deemed inadequate and did not sufficiently address the underlying design flaws.

Moreover, the lawsuit argues that because of these ongoing issues, there was a raised likelihood that customers would have to remove existing Novum LVPs from service altogether, leading to a complete halt of new sales of these pumps. Given these developments, the lawsuit asserts that Baxter's public statements regarding the product's safety, efficacy, and market performance were materially false and misleading.

How to Participate

If you have experienced financial losses due to your investment in Baxter International during this specified period, it is crucial to take action promptly. Investors have until December 15, 2025, to apply for lead plaintiff status. Participating in this lawsuit does not require you to be a lead plaintiff to obtain compensation; however, you must be a member of the class to have a claim.

No Cost to Participate

One of the significant advantages for class members is that participation comes with no upfront costs. Any potential compensation will not require out-of-pocket expenses or fees, allowing more investors to seek justice without financial barriers.

Why Choose Levi & Korsinsky

Levi & Korsinsky LLP has an esteemed history of successfully advocating for aggrieved shareholders. Over the past 20 years, the firm has recovered substantial sums for its clients and has a proven track record in high-stakes securities litigation. With a dedicated team of over 70 professionals, the firm is consistently recognized among the top securities litigation firms in the United States by ISS Securities Class Action Services' Top 50 Report.

For further inquiries or to explore your options, you can reach out to Joseph E. Levi, Esq. at Levi & Korsinsky via email at [email protected] or by calling (212) 363-7500.

Important Contact Details

• - Firm Name: Levi & Korsinsky, LLP
• - Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
• - Email: [email protected]
• - Phone: (212) 363-7500

This class action represents a critical opportunity for Baxter International investors to seek redress for the injuries they may have suffered due to the alleged negligence and misrepresentation by the company. Ensure you act before the deadline to safeguard your rights as an investor.